Publications by authors named "K Poppe"

Article Synopsis
  • Heart age is a tool used to help younger patients understand their long-term cardiovascular risks, even if their short-term risk appears low.
  • A study on New Zealand patients showed that while short-term CVD risk increases with age, heart age gaps generally decrease, highlighting differences between age groups.
  • Misusing heart age to guide medication decisions may not be appropriate since it does not directly correlate with short-term CVD risk, leading to potential misunderstandings in patient care.
View Article and Find Full Text PDF

Background And Aims: Frailty is increasingly prevalent in people presenting with acute coronary syndrome (ACS). This high-risk group is typically excluded from trials of interventions in ACS, and there is uncertainty about the risks and benefits of invasive management.

Methods: Patients with an ACS diagnosis between 2010 and 2015 in England were identified from Hospital Episode Statistics, with linked Office for National Statistics mortality data.

View Article and Find Full Text PDF

Aim: There is no consensus on the optimal time horizon for predicting cardiovascular disease (CVD) risk to inform treatment decisions. New Zealand and Australia recommend 5 years, whereas most countries recommend 10 years. We compared predicted risk and treatment-eligible groups using 5-year and 10-year equations.

View Article and Find Full Text PDF

Purpose Of Review: To analyze whether pregnancy could play a role in the higher prevalence of differentiated thyroid carcinoma (DTC) in women. Estrogens strongly modify thyroid economy by increasing iodine clearance, thyroid hormone requirement and production. Human chorionic gonadotropin (hCG) contributes to the increased thyroid hormone synthesis.

View Article and Find Full Text PDF

Purpose Of Review: To analyze the reciprocal influences between female reproductive life and DTC management.

Recent Findings: Data on pregnancy outcome in DTC patients indicate that after conceiving, these women may need an increased L-T4 dose to maintain suppressed serum TSH levels. Nevertheless, this does not determine major harm in terms of pregnancy outcome.

View Article and Find Full Text PDF